Clinical Trial

Assessment of CCM in HF With Higher Ejection Fraction

Name: Assessment of CCM in HF With Higher Ejection Fraction — clinical trial record (NCT05064709)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: AIM HIGHer

Recruiting

View on ClinicalTrials.gov →

Summary

The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤70%.

Protocol Amendment History 1 change

notable Trial sites reduced: 112 -> 105 locations 2026-05-07

Trial Details

NCT Number	NCT05064709
Lead Sponsor	Impulse Dynamics
Conditions	Heart Failure, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range Ejection Fraction, Heart Failure With Moderately Reduced Ejection Fraction, Diastolic Heart Failure
Enrollment	1,500 participants
Start Date	2022-02-03
Primary Completion	2029-02-01 (estimated)
Study Completion	2029-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-06